Association of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus

NCT01997424 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

340

Enrollment

OTHER

Sponsor class

Conditions

Non-alcoholic Fatty Liver Disease (NAFLD)

Interventions

DEVICE: Controlled Attenuation Parameter (CAP), Echosens, Paris, France
DEVICE: FibroScan, Echosens, Paris, France

Sponsor

Johann Wolfgang Goethe University Hospital